Inactive Instrument

Iomai Corporation Stock

Stocks

US46202P1030

Pharmaceuticals

End-of-day quote
- - Intraday chart for Iomai Corporation
Manager TitleAgeSince
Corporate Officer/Principal 59 2015-11-30
Director of Finance/CFO 56 -
Corporate Officer/Principal - 2008-07-31
Director TitleAgeSince
Director/Board Member 87 2006-07-04
Director/Board Member 83 2005-12-31
Director/Board Member 73 2001-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%+2.44%+38.43%-0.30% 80.23B
-1.02%-0.51%-2.54%+26.80% 50.64B
-3.10%-4.84%+10.29%+158.34% 46.87B
-0.74%+3.26%-49.51%-49.96% 46.34B
-0.39%+0.91%+51.39%-22.35% 31B
-0.52%+7.01%+125.98%-34.32% 25.28B
-0.30%-0.33%+38.24%+83.70% 24.36B
-1.42%-1.11%-3.79%+190.40% 20.81B
-1.83%-2.82%+60.85%+107.54% 16.08B
Average -1.07%+1.44%+29.93%+51.09% 37.96B
Weighted average by Cap. -1.02%+1.13%+22.69%+36.91%
Logo Iomai Corporation
Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.
Employees
-